Correlation Between Apellis Pharmaceuticals and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Alnylam Pharmaceuticals.
Diversification Opportunities for Apellis Pharmaceuticals and Alnylam Pharmaceuticals
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Alnylam is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.36 times more return on investment than Alnylam Pharmaceuticals. However, Apellis Pharmaceuticals is 1.36 times more volatile than Alnylam Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Alnylam Pharmaceuticals |
Apellis Pharmaceuticals and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Alnylam Pharmaceuticals
The main advantage of trading using opposite Apellis Pharmaceuticals and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |